Controlling a multicenter outbreak involving the New York/Japan methicillin-resistant Staphylococcus aureus clone

Infection Control and Hospital Epidemiology

Volumn 28, Issue 7, 2007, Pages 845-852

  Coombs, Geoffrey W ^a,b   Van Gessel, H ^a   Pearson, J C ^a   Godsell, M R ^c   O'Brien, F G ^a,b   Christiansen, K J ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c Clinical Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CETRIMIDE; CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; HEXACHLOROPHENE; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TRIMETHOPRIM;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; EPIDEMIC; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; JAPAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PANDEMIC; UNITED STATES;

BACTERIAL TYPING TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WESTERN AUSTRALIA;

EID: 34447318103     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/518726     Document Type: Article

References (40)

1. de Lancastre H, Severina EP, Roberts RB, Kreiswirth BN, Tomasz A. Testing the efficacy of a molecular surveillance network: methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the metropolitan New York city area. The BARG Initiative Pilot Study Group. Bacterial Antibiotic Resistance Group. Microb Drug Resist 1996; 2:343-351.
2. Roberts RB, de Lancastre A, Eisner W, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York Hospitals. J Infect Dis 1998; 178:164-171.
3. Roberts RB, Chung M, de Lancastre H, et al. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey and Pennsylvania. Microb Drug Resist 2000; 6:245-251.
4. Aires de Sousa A, De Lencastre H, Santos Sanches I, Kikuchi K, Totsuka T, Tomasz A. Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in New York City and in a hospital in Tokyo, Japan. Microb Drug Resist 2000; 6:253-258.
5. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol 1995; 39:531-543.
6. Tanaka T, Okuzumi K, Iwamoto A, Hiramatsu K. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J Infect Chemother 1995; 1:40-49.
7. da Silva Coimbra MV, Silva-Carvalho MC, Wisplinghoff H, et al. Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J Hosp Infect 2003; 53:103-110.
8. Chung M, Dickinson G, de Lencastre H, Tomasz A. International clones of methicillin-resistant Staphylococcus aureus in two hospitals in Miami, Florida. J Clin Microbiol 2004; 42:542-547.
9. O'Brien FG, Lim TT, Winnett DC, et al. Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas. J Clin Microbiol 2005; 43:2969-2972.
10. Simor AE, Ofner-Agostini M, Bryce E, et al. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995- 1999. J Infect Dis 2002; 186:652-260.
11. Melo MCN, Silva-Carvalho MC, Ferrerira RL, et al. Detection and molecular characterization of a gentamicin-susceptible, methicillin-resistant Staphylococcus aureus (MRSA) clone in Rio de Janeoro that resembles the New York/Japanese clone. J Hosp Infect 2004; 58:276-285.
12. Velazquez-Meza ME, Aires de Sousa M, Echaniz-Aviles G, et al. Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997-2003): clonal evolution and impact of infection control. J Clin Microbiol 2004; 42:3877-3880.
13. Ip M, Yung RWH, Ng TK, et al. Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong. J Clin Microbiol 2005; 43:5069-5073.
14. Cha HY, Moon DC, Choi CH, et al. Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean Hospital. J Clin Microbiol 2005; 43:3610-3614.
15. Soo Ko K, Kim Y-S, Song J-H, et al. Genotypic diversity of methicillin-resistant Staphylococcus aureus isolated in Korean hospitals. Antimicrob Agents Chemother 2005; 49:3583-3585.
16. Conceição T, Aires M, deSousa M, et al. Massive spread of the New York/Japan MRSA clone (ST5-SCCmec II) in a European country. In: Program and abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases (Nice, France). 2006. Abstract o311. Available at: http://www. blackwellpublishing.com/eccmidl6/abstract.asp?id=49162. Accessed July 2006.
17. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113-5120.
18. Nimmo GR, Bell JM, Mitchell D, et al. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals 1989-1999. Microb Drug Resist 2003; 9:155-160.
19. Coombs GW, Pearson JC, O'Brien FG, Murray RJ, Grubb WB, Christiansen KJ. Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis 2006; 12:241-247.
20. Wenzel RP, Reagan DR, Bertino JS Jr, Baron EJ, Arias K. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control 1998; 26:102-110.
21. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. 8th ed. Wayne, PA: NCCLS; 2003:M2-A8.
22. Comité de l'Antibiogramme de la Société Française de Microbiologic Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie: technicla recommendations for in vitro susceptibility testing. Clin Microbiol and Infect 1996; 2(suppl 1):S48.
23. Finlay JE, Miller LA, Poupards JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997;41:1137-1139.
24. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement. Wayne, PA: CLSI; 2005:M100-S15.
25. Goh S-H, Bryne SK, Zhang JL, Chow AW. Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 1992; 30:1642-1645.
26. O'Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. Community strains of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 1999; 37:2858-2862.
27. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-1015.
28. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-4294.
29. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawas H, Hiramatsu K. Identification of a novel staphylococcal cassette chromosome mec (type V) driven by a novel cassette chromosome ccrC. Antimicrob Agents Chemother 2004; 48:2637-2651.
30. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. J Hosp Infect 1986; 7:193-201.
31. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. MJA 2006; 184:384-388.
32. Farr BM. Doing the right thing (and figuring out what that is). Infect Control Hosp Epidemiol 2006; 27:999-1003.
33. Farr BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 2006; 27:1096-1106.
34. Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169-175.
35. Taneike I, Otsuka T, Dohmae S, et al. Molecular nature of methicillin-resistant Staphylococcus aureus derived from explosive nosocomial outbreaks of the 1980s in Japan. FEBS Lett 2006; 580:2323-2334.
36. Huang Y-C, Su L-H, Wu T-L, Lin T-Y. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates from a teaching hospital in northern Taiwan. J Clin Microbiol 2006; 44:2268-2270.
37. Pearman JW, Coombs GW, Grubb WB, O'Brien F. A British epidemic strain of methicillin-resistant Staphylococcus aureus (UK EMRSA-15) in Western Australia. Med J Aust 2001; 174:662.
38. Wang J-T, Chang S-C, Ko W-J, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect 2001; 47:104-109.
39. Bertin ML, Vinski J, Schmitt S, et al. Outbreak of methicillin-resistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis. Infect Control Hosp Epidemiol 2006; 27:581-585.
40. Blok HE, Troelstra A, Titia EM, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infect Control Hosp Epidemiol 2003; 24:679-685.